NeoCitran Grippe Erkältung FORTE
NeoCitran Grippe Erkältung FORTE is a medicine authorised by Swissmedic under authorisation number 68894. The authorisation holder is Haleon Schweiz AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 17 October 2023 and the authorisation is limited until 16 October 2028. ATC code N02BE51 places the medicine in the group Analgesics.
| Authorisation number | 68894 |
|---|---|
| Name | NeoCitran Grippe Erkältung FORTE |
| Full name | NeoCitran Grippe Erkältung FORTE, Pulver zur Herstellung einer Lösung zum Einnehmen |
| Authorisation holder | Haleon Schweiz AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | N02BE51 |
| First authorisation | 17 October 2023 |
| Authorisation validity | 16 October 2028 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | NeoCitran Grippe Erkältung FORTE, Pulver zur Herstellung einer Lösung zum Einnehmen | B | 17 October 2023 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 10 | Beutel | N02BE51 | 01.01.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is NeoCitran Grippe Erkältung FORTE authorised in Switzerland?
Yes. NeoCitran Grippe Erkältung FORTE is authorised by Swissmedic under authorisation number 68894, data as of 01 September 2026. The authorisation is limited until 16 October 2028.
Which dispensing category does NeoCitran Grippe Erkältung FORTE have?
NeoCitran Grippe Erkältung FORTE is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of NeoCitran Grippe Erkältung FORTE?
The authorisation holder is Haleon Schweiz AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.